Stanford Digital Repository

Tackling fate-bias in hematopoietic stem cells: a focused study on Neogenin-1 and a broader study on the relationship between their transcriptome and proteome

Placeholder Show Content

Abstract/Contents

Abstract
Hematopoietic stem cells (HSCs) supply the blood and immune cells of the body throughout life. A dysfunctional hematopoietic system can lead to a weakened immune system and predisposition to certain hematopoietic malignancies. Gaining a better understanding of HSCs can allow us to combat the weaknesses and disease in the blood system of the human body. Here we study the hematopoietic system of mice to identify Neogenin-1 (NEO1) as a transmembrane protein whose expression is highly specific to true long-term HSCs distinguishable based on the expression level of Hoxb5. In young mice, NEO1+ LT-HSCs demonstrate myeloid-bias, and the same population of LT-HSCs expands with age. In the process of demonstrating that NEO1+ LT-HSCs continued to demonstrate phenotypes of myeloid-bias even in older mice, we also demonstrate that Hoxb5, although previously reported to be a good marker for distinguishing LT-HSCs from ST-HSCs in young mice, is no longer a good marker for distinguishing LT-HSCs from ST-HSCs in old. A mouse model (Hoxb5CreERT2/Neo1fl/fl/Rosa26mTmG) was additionally generated to genetically manipulate Neo1 in the context of HSCs and has been marginally validated thus far. A more detailed, molecular study on Neo1 transcripts in bulk LT-HSCs revealed that both NEO1+ LT-HSCs and NEO1- LT-HSCs contained transcripts of Neo1. The former predominantly had a computationally predicted splice variant, and the latter largely dominated by a completely novel splice variant retaining the intron between exons 16 and 17. This intron retention introduces a premature termination codon that likely leads to the downregulation of surface NEO1 in NEO1- LT-HSCs. This evidence of complex post-transcriptional regulation of gene expression in HSCs motivated a project broadly comparing the proteome and transcriptome of various hematopoietic stem and progenitor cells. This comparison revealed that hematopoietic stem cells from young mice have an unusually low proteomic diversity as well as greater discordance between protein and transcript expression in comparison to other progenitor cell types. Interestingly, the low proteomic diversity is no longer observed in HSCs of old mice. These comparative analyses provide further corroboration of the complex post-transcriptional regulation that may be present in young mouse hematopoietic stem cells (possibly through the control of ribosomes and miRNAs) which either seems to change with age or is hidden by an increase in heterogeneity of what is immunophenotypically defined as “HSCs” that accompanies aging in mice. Put together, this body of work paves the way for new, meaningful research investigating 1) the role of post-transcriptional regulation in hematopoietic stem cell maintenance and cell fate; 2) the interactions between the surface proteins present on HSCs and proteins present on cells comprising the HSC niche; and 3) how those two relate to and can be used to counteract any immunodeficiencies or hematological disorders.

Description

Type of resource text
Date created June 2021
Date modified December 5, 2022
Publication date May 6, 2022

Creators/Contributors

Author Noh, Joseph J
Degree granting institution Stanford University, Department of Biology
Thesis advisor Weissman, Irving L
Thesis advisor Jones, Patricia P

Subjects

Subject Biology
Subject Neogenin-1
Subject Hematopoietic Stem Cells
Subject Splice Variants
Subject Proteomics
Subject Transcriptomics
Genre Text
Genre Thesis

Bibliographic information

Related item
Preferred citation
Zaro, B. W., Noh, J. J., Mascetti, V. L., Demeter, J., George, B., Zukowska, M., Gulati, G. S., Sinha, R., Flynn, R. A., Banuelos, A., Zhang, A., Wilkinson, A. C., Jackson, P. & Weissman I. L. (2020). Proteomic analysis of young and old mouse hematopoietic stem cells and their progenitors reveals post-transcriptional regulation in stem cells. eLife, 9, e62210. doi: 10.7554/eLife.62210
Preferred citation
Gulati, G. S., Zukowska, M., Noh, J. J., Zhang, A., Wesche, D. J., Sinha, R., George, B. M., Weissman, I. L. & Szade, K. (2019). Neogenin-1 distinguishes between myeloid-biased and balanced Hoxb5+ mouse long-term hematopoietic stem cells. Proceedings of the National Academy of Sciences, 116(50), 25115-25125. doi: 10.1073/pnas.1911024116
Location https://purl.stanford.edu/tk413js8666

Access conditions

Use and reproduction
User agrees that, where applicable, content will not be used to identify or to otherwise infringe the privacy or confidentiality rights of individuals. Content distributed via the Stanford Digital Repository may be subject to additional license and use restrictions applied by the depositor.
License
This work is licensed under a Creative Commons Attribution Share Alike 3.0 Unported license (CC BY-SA).

Preferred citation

Noh, Joseph J and Weissman, Irving L and Jones, Patricia P. (2021). Tackling fate-bias in hematopoietic stem cells: a focused study on Neogenin-1 and a broader study on the relationship between their transcriptome and proteome. Stanford Digital Repository. Available at: https://purl.stanford.edu/tk413js8666

Collection

Undergraduate Theses, Department of Biology, 2020-2021

View other items in this collection in SearchWorks

Contact information

jnoh2@stanford.edu

Also listed in

View in SearchWorks

Loading usage metrics...